The reported statements, read against the company's own industry.
Financials view
Market Capitalization
4.16BCNY
618.98M · vs all stocks (USD)
Updated Aug 21, 2026
Revenue (TTM)
922.96MCNY
137.25M · vs all stocks (USD)
Updated Aug 21, 2026
Profit Margin
-6.92%
vs Pollution & Treatment Controls peers
Updated Aug 21, 2026
Beta
0.3870x
vs all stocks
Updated Aug 21, 2026
52-Week Change
-0.29%
vs all stocks
Updated Aug 21, 2026
Market Capitalization
4.16BCNY
618.98M · vs all stocks (USD)
Updated Aug 21, 2026
Enterprise Value
4.75BCNY
706.62M · vs all stocks (USD)
Updated Aug 21, 2026
Forward P/E
20.46x
vs Pollution & Treatment Controls peers
Updated Aug 21, 2026
Price to Sales (TTM)
4.57x
vs Pollution & Treatment Controls peers
Updated Aug 21, 2026
Price to Book (MRQ)
2.50x
vs Pollution & Treatment Controls peers
Updated Aug 21, 2026
Enterprise to Revenue
5.15x
vs Pollution & Treatment Controls peers
Updated Aug 21, 2026
Gross Margin
17.36%
vs Pollution & Treatment Controls peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 19.93%.Updated Aug 21, 2026
Profit Margin
-6.92%
vs Pollution & Treatment Controls peers
Updated Aug 21, 2026
Operating Margin
-24.28%
vs Pollution & Treatment Controls peers
Updated Aug 21, 2026
Return on Assets (TTM)
-1.40%
vs Pollution & Treatment Controls peers
Updated Aug 21, 2026
Return on Equity (TTM)
-3.99%
vs Pollution & Treatment Controls peers
Updated Aug 21, 2026
Revenue (TTM)
922.96MCNY
137.25M · vs all stocks (USD)
Updated Aug 21, 2026
Revenue per Share (TTM)
6.35CNYUpdated Aug 21, 2026
Quarterly Revenue Growth
-63.10%
vs Pollution & Treatment Controls peers
Updated Aug 21, 2026
Gross Profit (TTM)
183.95MCNY
27.36M · vs all stocks (USD)
Updated Aug 21, 2026
EBITDA (TTM)
73.96MCNY
11.00M · vs all stocks (USD)
Updated Aug 21, 2026
Net Income (TTM)
-63.84MCNY
-9.49M · vs all stocks (USD)
Updated Aug 21, 2026
Quarterly Earnings Growth (YoY)
-74.07%
vs Pollution & Treatment Controls peers
Updated Aug 21, 2026
Operating Cash Flow (TTM)
-118.89MCNY
-17.68M · vs all stocks (USD)
Updated Aug 21, 2026
Levered Free Cash Flow (TTM)
-187.69MCNY
-27.91M · vs all stocks (USD)
Updated Aug 21, 2026
5-Year Average Dividend Yield
0.73%
vs all stocks
Updated Aug 21, 2026
Payout Ratio
31.25%
vs Pollution & Treatment Controls peers
Updated Aug 21, 2026
Minority Interest (Equity)
9.88MCNYFY2025 · Dec 31, 2025
Revenue
1.13BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
886.67MCNYFY2025 · Dec 31, 2025
Gross Profit
238.96MCNYFY2025 · Dec 31, 2025
Operating Income
7.46MCNY
1.11M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-28.77MCNYFY2025 · Dec 31, 2025
Income Tax Expense
-9.94MCNYFY2025 · Dec 31, 2025
Net Income
-18.83MCNYFY2025 · Dec 31, 2025
EBIT
-4.36MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
73.96MCNYFY2025 · Dec 31, 2025
Research & Development
97.49MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
38.56MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
10.62MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
1.38MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
24.41MCNYFY2025 · Dec 31, 2025
EPS (Basic)
-0.1200CNYFY2025 · Dec 31, 2025
EPS (Diluted)
-0.1200CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
142.58MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
142.58MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-18.83MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
1.72MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
216.43MCNYFY2025 · Dec 31, 2025
Free Cash Flow
94.38MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
221.02MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-18.83MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
28.10MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
144.56MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
62.61MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-122.05MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-122.05MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
557.94MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-415.21MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-36.18MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-61.36MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
45.19MCNYFY2025 · Dec 31, 2025
Shares Outstanding
147.68MSharesUpdated Aug 21, 2026
Float Shares
51.14MSharesUpdated Aug 21, 2026
% Held by Insiders
66.19%
vs all stocks
Updated Aug 21, 2026
% Held by Institutions
0.33%
vs all stocks
Updated Aug 21, 2026
Total Cash (MRQ)
260.77MCNY
38.78M · vs all stocks (USD)
Updated Aug 21, 2026
Total Cash per Share (MRQ)
1.78CNYUpdated Aug 21, 2026
Total Debt (MRQ)
1.01BCNY
150.48M · vs all stocks (USD)
Updated Aug 21, 2026
Total Debt to Equity (MRQ)
0.6171x
vs Pollution & Treatment Controls peers
Updated Aug 21, 2026
Current Ratio (MRQ)
1.56x
vs Pollution & Treatment Controls peers
Updated Aug 21, 2026
Book Value per Share (MRQ)
11.13CNYUpdated Aug 21, 2026
Total Assets
3.39BCNY
503.62M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
1.95BCNYFY2025 · Dec 31, 2025
Total Liabilities
1.72BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
1.44BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
434.47MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
1.28BCNYFY2025 · Dec 31, 2025
Cash
221.03MCNYFY2025 · Dec 31, 2025
Cash Equivalents
74.35MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
295.38MCNYFY2025 · Dec 31, 2025
Accounts Receivable
812.81MCNYFY2025 · Dec 31, 2025
Inventory
668.97MCNYFY2025 · Dec 31, 2025
Accounts Payable
645.79MCNYFY2025 · Dec 31, 2025
Short-term Debt
544.56MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
741.46KCNYFY2025 · Dec 31, 2025
Long-term Debt
432.38MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
147.68MCNYFY2025 · Dec 31, 2025
Retained Earnings
714.43MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
1.67BCNY
248.54M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
74.27MCNYFY2025 · Dec 31, 2025
52-Week Low
22.61CNYUpdated Aug 21, 2026
52-Week High
56.39CNYUpdated Aug 21, 2026
52-Week Change
-0.29%
vs all stocks
Updated Aug 21, 2026
Beta
0.3870x
vs all stocks
Updated Aug 21, 2026
50-Day MA
34.82CNYUpdated Aug 21, 2026
200-Day MA
28.26CNYUpdated Aug 21, 2026
Avg 10-Day Volume
4.31MSharesUpdated Aug 21, 2026
Avg 30-Day Volume
6.06MSharesUpdated Aug 21, 2026
Diluted EPS (TTM)
-0.4400CNYUpdated Aug 21, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
Partial Recovery After Sharp Decline
A weak, thin-volume bounce inside a decline that is still far from recovered.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.